Optimizing Treatment for Patients With Juvenile Idiopathic Arthritis in Sustained Remission: The MOVE-JIA Trial

PHASE4RecruitingINTERVENTIONAL
Enrollment

150

Participants

Timeline

Start Date

October 24, 2024

Primary Completion Date

December 31, 2027

Study Completion Date

December 31, 2029

Conditions
Juvenile Idiopathic Arthritis
Interventions
DRUG

Methotrexate

Gradual withdrawal of the medication

DRUG

TNF Inhibitor

Gradual withdrawal of the medication

Trial Locations (7)

3004

RECRUITING

Drammen Hospital, Drammen

4019

RECRUITING

Stavanger University Hospital, Stavanger

4615

RECRUITING

Hospital of Southern Norway Hospital Trust, Kristiansand

5009

RECRUITING

Haukeland University Hospital, Bergen

7030

RECRUITING

St. Olavs Hospital, Trondheim

9019

RECRUITING

University Hospital of North Norway, Tromsø

0372

RECRUITING

Oslo University Hospital, Oslo

All Listed Sponsors
collaborator

The Research Council of Norway

OTHER

collaborator

South-Eastern Norway Regional Health Authority

OTHER

collaborator

Remedy

INDUSTRY

lead

Oslo University Hospital

OTHER

NCT06653634 - Optimizing Treatment for Patients With Juvenile Idiopathic Arthritis in Sustained Remission: The MOVE-JIA Trial | Biotech Hunter | Biotech Hunter